Go Pro

Avalon GloboCare (ALBT) Competitors

Avalon GloboCare logo
$0.28 0.00 (-1.06%)
Closing price 07/21/2026
Extended Trading
$0.28 0.00 (0.00%)
As of 07/21/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ALBT vs. JF, CYN, APCX, SMSI, and AIXC

Should you buy Avalon GloboCare stock or one of its competitors? MarketBeat compares Avalon GloboCare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avalon GloboCare include J And Friends (JF), Cyngn Inc. Common Stock (CYN), AppTech Payments (APCX), Smith Micro Software (SMSI), and Qualigen Therapeutics (AIXC). These companies are all part of the "application software" industry.

How does Avalon GloboCare compare to J And Friends?

Avalon GloboCare (NASDAQ:ALBT) and J And Friends (NASDAQ:JF) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avalon GloboCare
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
J And Friends
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Avalon GloboCare has a beta of -0.03, suggesting that its share price is 103% less volatile than the broader market. Comparatively, J And Friends has a beta of 1.02, suggesting that its share price is 2% more volatile than the broader market.

1.4% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 6.6% of J And Friends shares are owned by institutional investors. 24.2% of Avalon GloboCare shares are owned by company insiders. Comparatively, 4.1% of J And Friends shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Avalon GloboCareN/A N/A -74.36%
J And Friends N/A N/A N/A

J And Friends has higher revenue and earnings than Avalon GloboCare.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.26M3.22-$18.26M-$3.51N/A
J And Friends$1.60M11.04-$1.32MN/AN/A

In the previous week, Avalon GloboCare's average media sentiment score of 0.00 equaled J And Friends'average media sentiment score.

Company Overall Sentiment
Avalon GloboCare Neutral
J And Friends Neutral

Summary

J And Friends beats Avalon GloboCare on 6 of the 7 factors compared between the two stocks.

How does Avalon GloboCare compare to Cyngn Inc. Common Stock?

Avalon GloboCare (NASDAQ:ALBT) and Cyngn Inc. Common Stock (NASDAQ:CYN) are both small-cap technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Avalon GloboCare has higher revenue and earnings than Cyngn Inc. Common Stock. Cyngn Inc. Common Stock is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.26M3.22-$18.26M-$3.51N/A
Cyngn Inc. Common Stock$220K81.28-$23.47M-$5.27N/A

Avalon GloboCare has a beta of -0.03, meaning that its share price is 103% less volatile than the broader market. Comparatively, Cyngn Inc. Common Stock has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market.

1.4% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 73.2% of Cyngn Inc. Common Stock shares are owned by institutional investors. 24.2% of Avalon GloboCare shares are owned by company insiders. Comparatively, 0.0% of Cyngn Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Avalon GloboCare has a net margin of 0.00% compared to Cyngn Inc. Common Stock's net margin of -9,413.00%. Avalon GloboCare's return on equity of 0.00% beat Cyngn Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Avalon GloboCareN/A N/A -74.36%
Cyngn Inc. Common Stock -9,413.00%-59.68%-48.18%

In the previous week, Cyngn Inc. Common Stock had 1 more articles in the media than Avalon GloboCare. MarketBeat recorded 1 mentions for Cyngn Inc. Common Stock and 0 mentions for Avalon GloboCare. Avalon GloboCare's average media sentiment score of 0.00 equaled Cyngn Inc. Common Stock'saverage media sentiment score.

Company Overall Sentiment
Avalon GloboCare Neutral
Cyngn Inc. Common Stock Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avalon GloboCare
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cyngn Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Summary

Avalon GloboCare beats Cyngn Inc. Common Stock on 7 of the 13 factors compared between the two stocks.

How does Avalon GloboCare compare to AppTech Payments?

AppTech Payments (NASDAQ:APCX) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Avalon GloboCare has a net margin of 0.00% compared to AppTech Payments' net margin of -3,119.45%. Avalon GloboCare's return on equity of 0.00% beat AppTech Payments' return on equity.

Company Net Margins Return on Equity Return on Assets
AppTech Payments-3,119.45% -398.98% -153.45%
Avalon GloboCare N/A N/A -74.36%

Avalon GloboCare has higher revenue and earnings than AppTech Payments. AppTech Payments is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AppTech Payments$276K55.54-$18.51M-$0.23N/A
Avalon GloboCare$1.26M3.22-$18.26M-$3.51N/A

5.2% of AppTech Payments shares are owned by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are owned by institutional investors. 44.5% of AppTech Payments shares are owned by company insiders. Comparatively, 24.2% of Avalon GloboCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AppTech Payments
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avalon GloboCare
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, AppTech Payments had 1 more articles in the media than Avalon GloboCare. MarketBeat recorded 1 mentions for AppTech Payments and 0 mentions for Avalon GloboCare. AppTech Payments' average media sentiment score of 0.00 equaled Avalon GloboCare'saverage media sentiment score.

Company Overall Sentiment
AppTech Payments Neutral
Avalon GloboCare Neutral

AppTech Payments has a beta of -0.44, suggesting that its stock price is 144% less volatile than the broader market. Comparatively, Avalon GloboCare has a beta of -0.03, suggesting that its stock price is 103% less volatile than the broader market.

Summary

Avalon GloboCare beats AppTech Payments on 8 of the 13 factors compared between the two stocks.

How does Avalon GloboCare compare to Smith Micro Software?

Smith Micro Software (NASDAQ:SMSI) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

In the previous week, Smith Micro Software's average media sentiment score of 0.00 equaled Avalon GloboCare'saverage media sentiment score.

Company Overall Sentiment
Smith Micro Software Neutral
Avalon GloboCare Neutral

Avalon GloboCare has lower revenue, but higher earnings than Smith Micro Software. Smith Micro Software is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith Micro Software$17.36M0.92-$29.33M-$6.90N/A
Avalon GloboCare$1.26M3.22-$18.26M-$3.51N/A

20.8% of Smith Micro Software shares are held by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are held by institutional investors. 34.7% of Smith Micro Software shares are held by company insiders. Comparatively, 24.2% of Avalon GloboCare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Smith Micro Software has a beta of 0.69, indicating that its share price is 31% less volatile than the broader market. Comparatively, Avalon GloboCare has a beta of -0.03, indicating that its share price is 103% less volatile than the broader market.

Smith Micro Software presently has a consensus price target of $12.50, suggesting a potential upside of 335.54%. Given Smith Micro Software's stronger consensus rating and higher possible upside, research analysts clearly believe Smith Micro Software is more favorable than Avalon GloboCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith Micro Software
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Avalon GloboCare
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Avalon GloboCare has a net margin of 0.00% compared to Smith Micro Software's net margin of -165.35%. Avalon GloboCare's return on equity of 0.00% beat Smith Micro Software's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith Micro Software-165.35% -55.78% -41.02%
Avalon GloboCare N/A N/A -74.36%

Summary

Smith Micro Software beats Avalon GloboCare on 8 of the 14 factors compared between the two stocks.

How does Avalon GloboCare compare to Qualigen Therapeutics?

Avalon GloboCare (NASDAQ:ALBT) and Qualigen Therapeutics (NASDAQ:AIXC) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

1.4% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 3.2% of Qualigen Therapeutics shares are owned by institutional investors. 24.2% of Avalon GloboCare shares are owned by company insiders. Comparatively, 1.2% of Qualigen Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Qualigen Therapeutics has lower revenue, but higher earnings than Avalon GloboCare. Qualigen Therapeutics is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.26M3.22-$18.26M-$3.51N/A
Qualigen TherapeuticsN/AN/A-$16.97M-$6.47N/A

In the previous week, Qualigen Therapeutics had 6 more articles in the media than Avalon GloboCare. MarketBeat recorded 6 mentions for Qualigen Therapeutics and 0 mentions for Avalon GloboCare. Qualigen Therapeutics' average media sentiment score of 0.30 beat Avalon GloboCare's score of 0.00 indicating that Qualigen Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Avalon GloboCare Neutral
Qualigen Therapeutics Neutral

Avalon GloboCare has a beta of -0.03, meaning that its stock price is 103% less volatile than the broader market. Comparatively, Qualigen Therapeutics has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avalon GloboCare
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Qualigen Therapeutics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Avalon GloboCare's return on equity of 0.00% beat Qualigen Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Avalon GloboCareN/A N/A -74.36%
Qualigen Therapeutics N/A -457.49%-69.64%

Summary

Qualigen Therapeutics beats Avalon GloboCare on 6 of the 11 factors compared between the two stocks.

Get Avalon GloboCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALBT vs. The Competition

MetricAvalon GloboCareSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$4.05M$15.93B$29.61B$12.95B
Dividend YieldN/A3.42%2.73%10.20%
P/E Ratio-0.08127.0274.9424.73
Price / Sales3.221,295.02596.25108.63
Price / CashN/A43.9150.5137.44
Price / Book-0.078.518.156.42
Net Income-$18.26M$437.06M$679.00M$347.12M
7 Day PerformanceN/A2.31%3.04%2.48%
1 Month Performance0.47%1.94%0.18%-1.04%
1 Year Performance-87.43%8.70%201.34%23.22%

Avalon GloboCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALBT
Avalon GloboCare
0.122 of 5 stars
$0.28
-1.1%
N/A-87.4%$4.05M$1.26MN/A5
JF
J And Friends
0.174 of 5 stars
$0.88
-2.1%
N/AN/A$16.18M$1.60MN/A78
CYN
Cyngn Inc. Common Stock
0.2417 of 5 stars
$1.12
-4.7%
N/AN/A$16.08M$220KN/A62
APCX
AppTech Payments
N/A$0.38
+7.7%
N/A+44.2%$15.83M$276KN/A20
SMSI
Smith Micro Software
2.1742 of 5 stars
$2.79
-0.5%
$12.50
+348.7%
-14.3%$15.57M$17.36MN/A370

Related Companies and Tools


This page (NASDAQ:ALBT) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners